Shell Asset Management CO Exact Sciences Corp Transaction History

Shell Asset Management CO

  • $2.26 Billion
  • Q1 2024

A detailed history of Shell Asset Management CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Shell Asset Management CO holds 1,532 shares of EXAS stock, worth $66,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,532
Previous 3,017 49.22%
Holding current value
$66,136
Previous $223,000 52.47%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$56.27 - $73.77 $83,560 - $109,548
-1,485 Reduced 49.22%
1,532 $106,000
Q4 2023

Feb 14, 2024
SELL
$59.06 - $75.72 $37,798 - $48,460
-640 Reduced 17.5%
3,017 $223,000
Q3 2023

Nov 08, 2023
BUY
$65.94 - $99.04 $9,627 - $14,459
146 Added 4.16%
3,657 $249,000
Q2 2023

Jul 28, 2023
BUY
$62.68 - $95.05 $41,180 - $62,447
657 Added 23.02%
3,511 $330,000
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $5,049 - $7,572
-107 Reduced 3.61%
2,854 $194,000
Q4 2022

Feb 07, 2023
SELL
$30.35 - $53.15 $65,222 - $114,219
-2,149 Reduced 42.05%
2,961 $147,000
Q2 2022

Aug 09, 2022
BUY
$35.61 - $76.23 $890 - $1,905
25 Added 0.49%
5,110 $201,000
Q1 2022

May 04, 2022
BUY
$57.56 - $82.54 $33,787 - $48,450
587 Added 13.05%
5,085 $356,000
Q4 2021

Feb 09, 2022
BUY
$72.5 - $100.68 $103,675 - $143,972
1,430 Added 46.61%
4,498 $350,000
Q3 2021

Nov 04, 2021
SELL
$90.24 - $124.05 $37,449 - $51,480
-415 Reduced 11.92%
3,068 $293,000
Q2 2021

Aug 12, 2021
SELL
$93.66 - $139.27 $112,860 - $167,820
-1,205 Reduced 25.7%
3,483 $433,000
Q1 2021

May 10, 2021
BUY
$116.57 - $155.01 $13,871 - $18,446
119 Added 2.6%
4,688 $618,000
Q4 2020

Feb 16, 2021
BUY
$99.61 - $142.12 $57,773 - $82,429
580 Added 14.54%
4,569 $605,000
Q2 2020

Aug 10, 2020
SELL
$55.75 - $92.75 $42,537 - $70,768
-763 Reduced 16.06%
3,989 $347,000
Q1 2020

May 11, 2020
SELL
$37.9 - $104.44 $215,196 - $593,010
-5,678 Reduced 54.44%
4,752 $276,000
Q4 2019

Feb 13, 2020
SELL
$77.66 - $99.74 $1.49 Million - $1.92 Million
-19,232 Reduced 64.84%
10,430 $965,000
Q3 2019

Nov 12, 2019
BUY
$90.37 - $122.49 $2,078 - $2,817
23 Added 0.08%
29,662 $2.68 Million
Q2 2019

Aug 12, 2019
BUY
$89.51 - $118.04 $655,123 - $863,934
7,319 Added 32.79%
29,639 $3.5 Million
Q1 2019

May 09, 2019
BUY
$61.98 - $96.5 $380,681 - $592,703
6,142 Added 37.97%
22,320 $1.93 Million
Q4 2018

Feb 13, 2019
SELL
$56.04 - $82.66 $227,690 - $335,847
-4,063 Reduced 20.07%
16,178 $1.02 Million
Q2 2018

Aug 10, 2018
BUY
$37.84 - $69.96 $195,481 - $361,413
5,166 Added 34.27%
20,241 $1.21 Million
Q3 2017

Oct 20, 2017
BUY
$37.05 - $47.12 $558,528 - $710,334
15,075
15,075 $710,000

Others Institutions Holding EXAS

# of Institutions
699
Shares Held
160M
Call Options Held
5.84M
Put Options Held
2.58M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.64B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email